Patents by Inventor Paert PETERSON

Paert PETERSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human anti-IFN-? antibodies
    Patent number: 11945861
    Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: April 2, 2024
    Assignee: IMMUNOQURE AG
    Inventors: Syeda F. Y. Haque, Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Steffen Meyer, Paert Peterson, Mike Rothe, Philip Vlaicu, Martin Woodward
  • HUMAN ANTI-IFN-ALPHA ANTIBODIES
    Publication number: 20210221883
    Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.
    Type: Application
    Filed: January 21, 2021
    Publication date: July 22, 2021
    Inventors: Syeda F. Y. HAQUE, Adrian HAYDAY, Kai KISAND, Kai KROHN, Annalisa MACAGNO, Steffen MEYER, Paert PETERSON, Mike ROTHE, Philip VLAICU, Martin WOODWARD
  • CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibody
    Patent number: 10975144
    Abstract: Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: April 13, 2021
    Assignee: ImmunoQure AG
    Inventors: Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Shimobi Onuoha, Paert Peterson, Mike Rothe, Martin Woodward, Syeda F. Y. Haque
  • Human anti-IFN-? antibodies
    Patent number: 10941198
    Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: March 9, 2021
    Inventors: Syeda F. Y. Haque, Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Steffen Meyer, Paert Peterson, Mike Rothe, Philip Vlaicu, Martin Woodward
  • HUMAN ANTI-IL-32 ANTIBODIES
    Publication number: 20190112367
    Abstract: Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.
    Type: Application
    Filed: August 21, 2018
    Publication date: April 18, 2019
    Inventors: Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Shimobi Onuoha, Paert Peterson, Mike Rothe, Martin Woodward, Syeda F. Y. Haque
  • HUMAN ANTI-IFN-ALPHA ANTIBODIES
    Publication number: 20190071499
    Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.
    Type: Application
    Filed: September 17, 2018
    Publication date: March 7, 2019
    Inventors: Syeda F. Y. HAQUE, Adrian HAYDAY, Kai KISAND, Kai KROHN, Annalisa MACAGNO, Steffen MEYER, Paert PETERSON, Mike ROTHE, Philip VLAICU, Martin WOODWARD
  • Human anti-IFN-? antibodies
    Patent number: 10112995
    Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: October 30, 2018
    Assignee: ImmunoQure AG
    Inventors: Syeda F. Y. Haque, Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Steffen Meyer, Paert Peterson, Mike Rothe, Philip Vlaicu, Martin Woodward
  • Human anti-IL-32 antibodies and methods of making and using the same
    Patent number: 10081676
    Abstract: Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: September 25, 2018
    Assignee: ImmunoQure AG
    Inventors: Adrian Hayday, Kai Kisand, Kai Krohn, Annalisa Macagno, Shimobi Onuoha, Paert Peterson, Mike Rothe, Martin Woodward, Syeda F. Y. Haque
  • HUMAN ANTI-IFN-ALPHA ANTIBODIES
    Publication number: 20170051055
    Abstract: Provided are novel IFN-? binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.
    Type: Application
    Filed: July 3, 2014
    Publication date: February 23, 2017
    Inventors: Syeda F.Y. HAQUE, Adrian HAYDAY, Kai KISAND, Kai KROHN, Annalisa MACAGNO, Steffen MEYER, Paert PETERSON, Mike ROTHE, Philip VLAICU, Martin WOODWARD
  • HUMAN ANTI-IL-32 ANTIBODIES
    Publication number: 20160368981
    Abstract: Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.
    Type: Application
    Filed: July 3, 2014
    Publication date: December 22, 2016
    Inventors: Andrian HAYDAY, Kai KISAND, Kai KROHN, Annalisa MACAGNO, Shimobi ONUOHA, Paert PETERSON, Mike ROTHE, Martin WOODWARD, Syeda F.Y. HAQUE
  • Gene defective in APECED and its use
    Patent number: 7785789
    Abstract: The present invention relates to a method for the diagnosis of a disease related to immune maturation and regulation of immune response towards self and nonself, comprising the steps of detecting in a biological specimen the presence of a DNA sequence comprising the sequence of SEQ ID NO:1.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: August 31, 2010
    Assignee: Finnish Immunotechnology Ltd.
    Inventors: Kai Krohn, Maarit Heino, Pärt Peterson, Hamish S Scott, Stylianos E. Antonarakis, Maria D. Lalioti, Nobuyoshi Shimizu, Jun Kudoh
  • Gene defective in APECED and its use
    Patent number: 7217806
    Abstract: The present invention relates to a novel gene, a novel protein encoded by said gene, a mutated form of the gene and to diagnostic and therapeutic uses of the gene or a mutated form thereof. More specifically, the present invention relates to a novel gene defective in autoimmune polyendocrinopathy syndrome type I (APS I), also called autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) (MIM No. 240,300).
    Type: Grant
    Filed: September 23, 1998
    Date of Patent: May 15, 2007
    Assignee: Finnish Immunotechnology Ltd.
    Inventors: Kai Krohn, Maarit Heino, Pärt Peterson, Hamish Scott, Stylianos Antonarakis, Maria Lalioti, Nobuyoshi Shimizu, Jun Kudoh